These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2126682)

  • 1. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms.
    Mohla S; White S; Grzegorzewski K; Nielsen D; Dunston G; Dickson L; Cha JK; Asseffa A; Olden K
    Anticancer Res; 1990; 10(6):1515-22. PubMed ID: 2126682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
    Dennis JW; Koch K; Yousefi S; VanderElst I
    Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of resident tissue-specific macrophages by swainsonine.
    Das PC; Roberts JD; White SL; Olden K
    Oncol Res; 1995; 7(9):425-33. PubMed ID: 8835286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
    Dennis JW
    Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors.
    Humphries MJ; Matsumoto K; White SL; Olden K
    Cancer Res; 1986 Oct; 46(10):5215-22. PubMed ID: 3093061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator.
    Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K
    Cancer Res; 1988 Mar; 48(6):1410-5. PubMed ID: 3125963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice.
    Fraker LD; Halter SA; Forbes JT
    Cancer Res; 1984 Dec; 44(12 Pt 1):5757-63. PubMed ID: 6498837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H; Reisfeld RA
    Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of macrophage tumoricidal activity, major histocompatibility complex class II antigen (Iak) expression, and interleukin-1 production by swainsonine.
    Grzegorzewski K; Newton SA; Akiyama SK; Sharrow S; Olden K; White SL
    Cancer Commun; 1989; 1(6):373-9. PubMed ID: 2484638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.